Physician profile
Alison Chan
NPI 1831189885
$1,099.19
in general payments reported to CMS, 2019-2025
9 companies · $338 in 2025
The $338 reported for 2025 was more than what 86% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.17 · 2020: $76.63 · 2021: $100 · 2022: $150 · 2023: $348 · 2024: $47.25 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $425 · Food and Beverage: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $425.00 |
| Food and Beverage | $308.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $828.90 | 2021-2025 | |
| Southern Implants North America INC | $64.35 | 2020 | |
| Dentsply Sirona INC | $48.02 | 2023-2025 | Q-Mix, Prime&Bond Nt Nano-Technology Light Cured Dental Adhesive |
| Solventum Corporation | $44.40 | 2025 | 3m Filtek, Clarity Aligners |
| Pulpdent Corporation | $32.44 | 2024 | |
| Voco America INC. | $29.63 | 2024-2025 | Admira Fusion X-Tra, Meron Plus Qm, Grandio So |
| Nobel Biocare USA | $27.74 | 2019 | |
| Septodont INC. | $12.28 | 2020 | |
| Dexcel Pharma Technologies Ltd. | $11.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.